High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma
Abstract Objective Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in combination with targeted therapies. Prognostic and predictive markers are needed, however, to identify patients amenable for these therapies. Methods Primary endometrial tumors were genotyped...
Saved in:
Published in | Gynecologic oncology Vol. 128; no. 2; pp. 327 - 334 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!